XML 157 R94.htm IDEA: XBRL DOCUMENT v3.25.1
Trade payables and other current liabilities - Additional Information (Details) - EUR (€)
€ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disclosure of Trade Payables and Other Current Liabilities [Line Items]        
Fixed assets payables € 200      
Increase in accrued expenses 4,200      
Accrued expenses - clinical trials 15,550 € 11,369    
Increase / (Decrease) in trade and other payables 1,959 8,675 € 2,905  
Trade payables & other accruals 4,484 6,695    
Decrease in payroll tax and other payroll liabilities   600    
Payroll tax and other payroll liabilities 6,300 6,900    
Decrease in bonus accrual 500      
Current contract liabilities 18,100 18,100    
ICON Plc        
Disclosure of Trade Payables and Other Current Liabilities [Line Items]        
Increase / (Decrease) in trade and other payables (2,200)      
LianBio, NBTXR3        
Disclosure of Trade Payables and Other Current Liabilities [Line Items]        
Current contract liabilities       € 16,500
1100 Study        
Disclosure of Trade Payables and Other Current Liabilities [Line Items]        
Accrued expenses - clinical trials 4,400 2,900    
NONORAY-312        
Disclosure of Trade Payables and Other Current Liabilities [Line Items]        
Accrued expenses - clinical trials 11,100 € 7,100    
NONORAY-312 | ICON Plc        
Disclosure of Trade Payables and Other Current Liabilities [Line Items]        
Increase / (Decrease) in trade and other payables € 2,600